The Verapamil Hydrochloride Extended, cataloged under National Stock Number 6505-01-330-7454, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Wilshire Pharmaceuticals, Inc Dba Wilshire Pharmaceuticals Inc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-330-7454 |
| Primary Part Number | NDC52536-0884-01 |
| Item Name | Verapamil Hydrochloride Extended |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Wilshire Pharmaceuticals, Inc Dba Wilshire Pharmaceuticals Inc |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 11.000 |
| Active Medicament Medicinal Strength | 240.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC52536-0884-01 PRIMARY | Wilshire Pharmaceuticals, Inc Dba Wilshire Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00591-2884-01 | 3/1 Design control — primary reference Societal Cdmo San Diego, Llc Dba Irisys Inc |
| NDC00591-2884-01 | 5/9 Secondary reference Teva Pharmaceuticals Usa, Inc. |
NSN 6505-01-330-7454 is a Verapamil Hydrochloride Extended, manufactured by Wilshire Pharmaceuticals, Inc Dba Wilshire Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-330-7454 has 1 manufacturer part number on file: NDC52536-0884-01 (Wilshire Pharmaceuticals, Inc Dba Wilshire Pharmaceuticals Inc).
Key specifications for NDC52536-0884-01: Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 11.000; Part Name Assigned by Controlling Agency: VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 240MG 100S BT; Active Medicament Medicinal Strength: 240.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.